COVID-19: Perspectives on the Regional Impact in Brazil — Edition 3 Presentations June 30, 2020 Maurício França Rafael Freixo
Related Practice Healthcare Services Much is still unknown or uncertain about COVID-19. In particular, data accuracy in Brazil is low due to the limited number of tests and the unavailability of granular public data. 01262022160122
Special Report Life Sciences & Pharma On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (Australia) November 11, 2025
Executive Insights Healthcare Services Surge in US C-SNPs: A Bright Spot in a Challenged Medicare Advantage Market May 22, 2025
Executive Insights Life Sciences & Pharma Animal Pharma: Unlocking Value Through Growth and Investment May 21, 2025
Article Healthcare Services Time for a Smarter Approach: Unlocking the Power of Strategic Pricing in European… May 16, 2025
Smart Chart Life Sciences & Pharma Radiotherapeutics on the Rise: Cracking the Supply Chain Code May 16, 2025
Executive Insights Healthcare Services Removing Barriers to Healthcare Growth: Leveraging Strategic Review to Address… April 14, 2025